Clinical Trial Update: Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting [NA]

View source ↗

Summary

This clinical trial update reports research identifying molecular signals in the vitreous humor associated with suboptimal response to VEGF inhibitors in neovas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Age Related Macular Degeneration | NA | Status: RECRUITING